Maple Leaf Green World (NEO:MGW,OTCQX:MGWFF) will be cultivating cannabigerol (CBG) enriched hemp seeds, a newly discovered, non-psychoactive cannabinoid that possesses potential in providing medical relief to ailments not found with cannabidiol CBD.
As quoted in the press release:
Although more research is required, the initial evaluation of CBG for medical applications shows great promise. With over 100 cannabinoid compounds identified, CBG is the precursor to which all other cannabinoids, such as THC and CBD, are synthesized.
The Company is also pleased to announce that renovation work has already begun on the 2 existing greenhouses at its 20 acres site at Riverside County, California. The renovations entail replacing all the covers and performing a complete sterilization to ensure a clean start up. The renovations are expected to be completed in mid-February, and cultivation will begin soon after.
Click here to read the full press release.
US Election 2020 and Cannabis
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
Recreational cannabis sales in Canada are on the rise, according to new Statistics Canada figures.
Also this past trading week, a cannabis producer in Canada was forced to make various staff layoffs.
<p>Keep reading to find out more cannabis highlights from the past five days.</p>
<div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing">
<img alt="US Election and Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/10/US-Election-2020-and-Cannabis-3D.jpg" title="US Election 2020 and Cannabis"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing">
<h2 align="center" class="ofie">US Election 2020 and Cannabis</h2></a>
<h5 align="center" class="subheadline">Investing in cannabis? Read what experts have to say about cannabis and the US Election!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
<h2>Adult cannabis sales yield C$255 million</h2>
<p><a href="https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=2010000801&pickMembers%5B0%5D=2.30&pickMembers%5B1%5D=3.1&cubeTimeFrame.startMonth=07&cubeTimeFrame.startYear=2020&cubeTimeFrame.endMonth=08&cubeTimeFrame.endYear=2020&referencePeriods=20200701%2C20200801" rel="noopener noreferrer" target="_blank">New data</a> from Statistics Canada indicates that the country’s recreational cannabis sales rose 5.2 percent in August compared to the previous month.</p>
<p>The Ontario market saw the biggest jump month-on-month, reporting a 10.9 percent sales spike from July to August. Alberta experienced only a small increase of 1.5 percent in sales despite having the most stores of any province in the country.</p>
<p><a href="https://www.bnnbloomberg.ca/cannabis-canada-pot-sales-climbed-5-to-new-monthly-record-in-august-1.1511342" rel="noopener noreferrer" target="_blank">According to BNN Bloomberg</a>, Stifel analyst Andrew Carter is penciling in the Canadian market for C$2.6 billion in sales throughout 2020.</p>
<h2>Producer lets go of 18 percent of its workforce</h2>
<p>VIVO Cannabis (TSX:<a href="https://investingnews.com/stock-information/?symbol=vivo:ca" rel="noopener noreferrer" target="_blank">VIVO</a>,OTCQX:VVCIF) <a href="https://www.newswire.ca/news-releases/vivo-cannabis-tm-streamlines-operations-815419399.html" rel="noopener noreferrer" target="_blank">confirmed to the market</a> that it has been forced to let go of approximately 45 staff members as part of a wide effort to reduce costs amid a turbulent year for operations in the Canadian cannabis market.</p>
<p>“These changes will allow VIVO to reduce costs by specializing resources and streamlining our organizational structure,” VIVO CEO <span class="xn-person">Barry Fishman said in a statement.</span></p>
<p>The workforce cuts were done after an internal review of the company’s operations. The company decided to restructure the work being done at its Napanee operation in Ontario</p>
<p>The changes go all the way up to VIVO’s board of directors, as the company announced Dan Laflamme will step down as director at the company.</p>
<h2>Cannabis company news</h2>
<ul class="ee-ul"><li><strong>Planet 13 Holdings (CSE:<a href="https://investingnews.com/stock-information/?symbol=plth:cnx" rel="noopener noreferrer" target="_blank">PLTH</a>,OTCQB:PLNHF) </strong><a href="https://www.newswire.ca/news-releases/planet-13-holdings-inc-announces-upsize-to-bought-deal-public-offering-870113835.html" rel="noopener noreferrer" target="_blank">informed the market</a> it is upping a new public offering to 5.8 million shares and targeting proceeds of C$25 million.</li>
</ul><ul class="ee-ul"><li><strong>The Green Organic Dutchman Holdings (TSX:<a href="https://investingnews.com/stock-information/?symbol=tgod:ca" rel="noopener noreferrer" target="_blank">TGOD</a>,OTCQX:TGODF) </strong>closed its <a href="https://www.newswire.ca/news-releases/the-green-organic-dutchman-holdings-ltd-announces-closing-of-approximately-12-75-million-bought-deal-including-the-full-exercise-of-the-over-allotment-option-835711653.html">most recent bought deal</a>, which saw over 53 million shares of the company offered at a price of C$0.24. The deal brought the company gross proceeds of C$12.75 million.</li>
</ul><ul class="ee-ul"><li><strong>AMP German Cannabis Group (CSE:<a href="https://investingnews.com/stock-information/?symbol=xcx:cnx" rel="noopener noreferrer" target="_blank">XCX</a>) </strong>announced it will <a href="https://www.newswire.ca/news-releases/-r-e-p-e-a-t-amp-german-cannabis-group-adds-little-green-pharma-medical-cannabis-extracts-from-australia-to-its-sales-offering--847078290.html">start offering products</a> from Australia-based producer Little Green Pharma (ASX:<a href="https://investingnews.com/stock-information/?symbol=lgp:au" rel="noopener noreferrer" target="_blank">LGP</a>) through its distribution business in the German medical cannabis market.</li>
</ul><ul class="ee-ul"><li><strong>Jushi Holdings (CSE:<a href="https://investingnews.com/stock-information/?symbol=jush:cnx" rel="noopener noreferrer" target="_blank">JUSH</a>,OTCQB:JUSHF) </strong><a href="https://www.newswire.ca/news-releases/jushi-holdings-inc-announces-closing-of-offering-of-subordinate-voting-shares-815274352.html" rel="noopener noreferrer" target="_blank">closed a special offering</a>, netting the company C$40.8 million in gross proceeds. It plans to employ the money for acquisitions and general business uses.</li>
</ul><p><em>Don’t forget to follow us <a href="https://twitter.com/inn_cannabis">@INN_Cannabis</a> for real-time updates!</em></p>
<p><strong>Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.</strong></p>
<div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/02/Profiting-From-Cannabis-2020-Outlook.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2020!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2020 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
DEADLINE ALERT for ACB and PGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
October 23 | 2020
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com .
<p> <strong> Aurora Cannabis, Inc. </strong> (NYSE: <a href="https://www.globenewswire.com/Tracker?data=O_abDmVerWfKIdv41T9aVUG_RxcRjbnv7r_xIdBoDsOUVr3eN7eYqd5irhbg4xLPX3Zr52DG0th2z8HlcPi4-A==" rel="nofollow noopener noreferrer" target="_blank"> ACB </a> ) <br/> Class Period: February 13, 2020 – September 4, 2020 <br/> Lead Plaintiff Deadline: <strong> December 1 </strong> <strong> , 2020 </strong> </p>
<p> <strong> <em> Shareholders with $50,000 losses or more are encouraged to contact the firm </em> </strong> </p>
<p> The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company had significantly overpaid for previous acquisitions and experienced degradation in certain assets, including its production facilities and inventory; (2) the Company’s purported “business transformation plan” and cost reset failed to mitigate the foregoing issues; (3) accordingly, it was foreseeable that Aurora would record significant goodwill and asset impairment charges; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. </p>
<p> <strong> Precigen, Inc. f/k/a </strong> <strong> Intrexon </strong> <strong> Corporation </strong> (NASDAQ: <a href="https://www.globenewswire.com/Tracker?data=yztkj9A3CDhJ9nkk6JlUFcUbxjc4cyy7KXj9VYd6-IlKfLW6heqYrS1ARQRUY24br5pHnJ3q0drR_hxGU7DbIg==" rel="nofollow noopener noreferrer" target="_blank"> PGEN </a> , XON) <br/> Class Period: May 10, 2017 – September 25, 2020 <br/> Lead Plaintiff Deadline: <strong> December </strong> <strong> 4 </strong> <strong> , 2020 </strong> </p>
<p> The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company was using pure methane as feedstock for its announced yields for its methanotroph bioconversion platform instead of natural gas; (2) yields from natural gas as a feedstock were substantially lower than the aforementioned pure methane yields; (3) due to the substantial price difference between pure methane and natural gas, pure methane was not a commercially viable feedstock; (4) the Company’s financial statements for the quarter ended March 31, 2018 were false and could not be relied upon; (5) the Company had material weaknesses in its internal controls over financial reporting; (6) the Company was under investigation by the SEC since October 2018; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. </p>
<p> Follow us for updates on Twitter: <a href="https://www.globenewswire.com/Tracker?data=exEXgbM6g7FcztPjAIZ5NtnTHBqeK5kSoQ2ZmsPxkBTNXet-yyiKxNYDT6C-pGzM5bOK7iBL60dKqgmnHVc0ufExT1kkPHFOpLNopZoH9TU=" rel="nofollow noopener noreferrer" target="_blank"> twitter.com/FRC_LAW </a> . </p>
<p> To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to <a href="https://www.globenewswire.com/Tracker?data=vII7dljG1TvQrhFGY_hMg9aM0lXEG71tw7dl9rtxhH-JCI9PCVkBi8W03WBdB5SpIJ_6WBhS5qspz37g5r9MO1vGWTO_2AXxuCeCIQEYJPw=" rel="nofollow noopener noreferrer" target="_blank"> info@frankcruzlaw.com </a> , or visit our website at <a href="https://www.globenewswire.com/Tracker?data=I8TafCngKWwx4T6pB0Uj_5rRQ3wMlDvcdchX4pcm8SXcC8PiutJF8YqhNGRqiAN6ajU-LX8wlSPc7NrJ0aR9TS_dOJCvKt_3a6A7kl7o0O8=" rel="nofollow noopener noreferrer" target="_blank"> www.frankcruzlaw.com </a> . If you inquire by email please include your mailing address, telephone number, and number of shares purchased. </p>
<p> This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. </p>
<p> Contacts </p>
<p> The Law Offices of Frank R. Cruz, Los Angeles <br/> Frank R. Cruz, 310-914-5007 <br/><a href="https://www.globenewswire.com/Tracker?data=4Sjkyvc8DRxBYcarAPnNHdnkqlFIGzngw-t604Fz2JtihGR_M1agg1ODDsSziGeoiiY_MngOTA69XKu5gPvVFNLj5kxQIdKdsNLPD26dtFs=" rel="nofollow noopener noreferrer" target="_blank"> fcruz@frankcruzlaw.com </a> <br/><a href="https://www.globenewswire.com/Tracker?data=I8TafCngKWwx4T6pB0Uj__rizOlr2cYQ7ZB8hEjAhfhGyOnzmVA7W4JqiuSM3Nbjrt3RTvxjYSByCkKZ1NpvDdsMRpzWGhFppqr-hryrWxw=" rel="nofollow noopener noreferrer" target="_blank"> www.frankcruzlaw.com </a> </p>
<p> <img class="lazy" data-src="https://www.globenewswire.com/newsroom/ti?nf=ODA3MjcwMiMzNzkxMTMyIzIxOTQyMzI=" data-srcset="" height="1" src="https://www.globenewswire.com/newsroom/ti?nf=ODA3MjcwMiMzNzkxMTMyIzIxOTQyMzI=" srcset="" width="1"/></p>
<p> <a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/778ea178-25d1-48a3-9141-a162814899d4" rel="noopener noreferrer" target="_blank"> <img alt="Primary Logo" border="0" class="lazy" data-src="https://ml.globenewswire.com/media/778ea178-25d1-48a3-9141-a162814899d4/small/close-up-logo-hd-blue-jpg.jpg" data-srcset="" height="82" src="https://ml.globenewswire.com/media/778ea178-25d1-48a3-9141-a162814899d4/small/close-up-logo-hd-blue-jpg.jpg" srcset="" width="150"/></a> </p>
</div>
<p>News Provided by GlobeNewswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing">
<img alt="US Election and Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/10/US-Election-2020-and-Cannabis-3D.jpg" title="US Election 2020 and Cannabis"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing">
<h2 align="center" class="ofie">US Election 2020 and Cannabis</h2></a>
<h5 align="center" class="subheadline">Investing in cannabis? Read what experts have to say about cannabis and the US Election!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Cronos Group Inc. to Hold 2020 Third Quarter Earnings Conference Call on November 5, 2020
October 23 | 2020
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Third Quarter Earnings Conference Call on Thursday, November 5, 2020 at 8:30 a.m. EST. Cronos Group’s senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.
A live audio webcast of the earnings call will be available on the Company’s website at https://ir.thecronosgroup.com/events-presentations . The webcast of the call will be archived for replay on the Company’s website.
<p align="justify"> Participants may also listen via telephone by dialing (866) 795-2258 toll-free from the U.S. and Canada, or (409) 937-8902 if dialing from outside the U.S. and Canada (passcode: 5159205). If joining by phone, please dial into the call 15-20 minutes earlier to avoid any long hold times. </p>
<p align="justify"> <strong> About Cronos Group Inc. <br/></strong> Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes <a href="https://www.peacenaturals.com/" rel="nofollow noopener noreferrer" target="_blank"> PEACE NATURALS </a> ™, a global wellness platform, two adult-use brands, <a href="https://covecannabis.ca/" rel="nofollow noopener noreferrer" target="_blank"> COVE </a> ™ and <a href="https://spinachcannabis.com/" rel="nofollow noopener noreferrer" target="_blank"> Spinach </a> ™, and three hemp-derived CBD brands, <a href="https://lordjones.com/" rel="nofollow noopener noreferrer" target="_blank"> Lord Jones </a> ™, <a href="https://doahappydance.com/" rel="nofollow noopener noreferrer" target="_blank"> Happy Dance </a> ™ and <a href="https://www.peaceplus.com/" rel="nofollow noopener noreferrer" target="_blank"> PEACE+ </a> ™. For more information about Cronos Group and its brands, please visit: <a href="http://www.thecronosgroup.com/" rel="nofollow noopener noreferrer" target="_blank"> www.thecronosgroup.com </a> . </p>
<p align="justify"> <strong> Forward-looking Statements <br/></strong> This press release may contain information that may constitute “forward‐looking information” or “forward‐looking statements” within the meaning of applicable Canadian and U.S. securities laws (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward‐looking Statements. In some cases, Forward‐looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward‐looking Statements. Some of the Forward-looking Statements contained in this press release include the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward‐looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward‐looking Statements and the Forward‐looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (as amended), the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020, the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2020, and the Company’s definitive proxy statement dated April 28, 2020, all of which have been filed on SEDAR and EDGAR and can be accessed at <a href="http://www.sedar.com" rel="nofollow noopener noreferrer" target="_blank"> www.sedar.com </a> and <a href="http://www.sec.gov/edgar" rel="nofollow noopener noreferrer" target="_blank"> www.sec.gov/edgar </a> , respectively. Any Forward‐looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos Group disclaims any obligation to update or revise any Forward‐ looking Statement. Readers are cautioned not to put undue reliance on any Forward‐looking Statement. </p>
<p> <strong> Cronos Group Contact </strong> <br/> Anna Shlimak <br/> Tel: (416) 504-0004 <br/><a href="mailto:investor.relations@thecronosgroup.com" rel="nofollow noopener noreferrer" target="_blank"> investor.relations@thecronosgroup.com </a> </p>
<p> <img class="lazy" data-src="https://www.globenewswire.com/newsroom/ti?nf=ODA3MjY2MSMzNzkxMDExIzIwOTYzMzk=" data-srcset="" height="1" src="https://www.globenewswire.com/newsroom/ti?nf=ODA3MjY2MSMzNzkxMDExIzIwOTYzMzk=" srcset="" width="1"/></p>
<p> <a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/30b4aee0-84f6-47b6-a7ff-2e1149d2177b" rel="noopener noreferrer" target="_blank"> <img alt="Primary Logo" border="0" class="lazy" data-src="https://ml.globenewswire.com/media/30b4aee0-84f6-47b6-a7ff-2e1149d2177b/small/cronos-black-png.png" data-srcset="" height="74" src="https://ml.globenewswire.com/media/30b4aee0-84f6-47b6-a7ff-2e1149d2177b/small/cronos-black-png.png" srcset="" width="150"/></a> </p>
</div>
<p>News Provided by GlobeNewswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing">
<img alt="US Election and Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/10/US-Election-2020-and-Cannabis-3D.jpg" title="US Election 2020 and Cannabis"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing">
<h2 align="center" class="ofie">US Election 2020 and Cannabis</h2></a>
<h5 align="center" class="subheadline">Investing in cannabis? Read what experts have to say about cannabis and the US Election!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
BioHarvest Sciences Inc. Appoints World Renowned Medical Physician and Nutritionist to Company Advisory Board
October 23 | 2020
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) announces that it has added Dr. David Brady as a member of its Advisory Board. Dr. Brady will act as a strategic advisor to the company in the area of developing and bringing to market superior science based functional nutraceutical product.
“The addition of Dr. Brady to our Advisory Board adds further credibility to the science behind our products such as VINIA® which is currently being sold in Israel and will be launched in the US in Q1 2021, as well as our unique pipeline of superfruits nutraceutical products,” stated BioHarvest Sciences CEO Ilan Sobel. “We look forward to embracing Dr. Brady’s wealth of clinical experience and knowledge of the industry and we are confident he will make a significant contribution to ensuring that we continue to deliver superior health and wellness solutions for our customers with our disruptive BioFarming technology. We will continue to assemble the best team of advisors to bring the benefits of our BioFarming technology to the world.” Dr. David Brady added: “I am honoured to join this exciting journey that BHSC has embarked on by applying its disruptive BioFarming technology to the nutraceuticals market and I look forward to working with the talented management team to bring superior science-based nutraceutical products to market”.
<p>Dr. Brady brings to the advisory board 30 years of experience as an integrative and nutritional medicine practitioner and over 25 years in health sciences academia. He is a licensed naturopathic medical physician in Connecticut and Vermont, is board certified in functional medicine and clinical nutrition, and is a fellow of the American College of Nutrition. Dr. Brady has been the Chief Medical Officer of Designs for Health, Inc. and also currently serves as the Chief Medical Officer for Diagnostic Solutions Labs, LLC. He was the long-time Vice President for health sciences and Director of the Human Nutrition Institute and continues to serve as an associate professor of clinical sciences, at the University of Bridgeport in Connecticut. He has published multiple peer-reviewed scientific papers and textbooks related to chronic pain, autoimmunity, and functional gastroenterology. Furthermore. Dr. Brady appeared on the plenary speaking panels of some of the largest and most prestigious conferences in the field including; IFM, ACAM, A4M, ACN, IHS, AANP, AIHM, and many more. </p>
<p><b>About <a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a></b></p>
<p>Based in Vancouver BC, <a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a> is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The Company’s technology is non-GMO and has already been validated by VINIA®, the red grapes cells functional food/dietary supplement produced and sold by <a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a> The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, <a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a>‘s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes. Visit: <a href="https://www.newsfilecorp.com/redirect/pjgMsw21w" rel="noopener noreferrer" target="_blank">www.bioharvest.com</a>.</p>
<p><b><a href="https://investingnews.com/company-profiles/bioharvest-sciences-cse:bhsc/">BioHarvest Sciences Inc.</a><br/></b>Ilan Sobel, Chief Executive Officer</p>
<p><b>For further information, please contact:<br/></b>Dave Ryan, VP Investor Relations & Director<br/>Phone: 1 (604) 622-1186<br/>Email: <a href="mailto:dave@bioharvest.com" rel="noopener noreferrer" target="_blank">dave@bioharvest.com</a></p>
<p><a href="https://www.newsfilecorp.com/redirect/YaJMSpJw5" rel="noopener noreferrer" target="_blank"></a></p>
<p><b>Forward-Looking Statements </b></p>
<p>Information set forth in this news release includes forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance that we will achieve our objective of being a leading supplier of Cannabis. Delays and cost overruns may result in delays in achieving our projected date for launch in the US market. Projected sales of Cannabis will require the company to obtain production and / or export licensing which cannot be assured.</p>
<p>All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. </p>
<p><b>Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.</b></p>
<p id="corporateNewsLogoContainer"><img alt="Corporate Logo" class="lazy" data-src="https://orders.newsfilecorp.com/files/6168/66735_5f1dc8fa7488281a_logo.jpg" data-srcset="" id="corporateNewsLogo" src="https://orders.newsfilecorp.com/files/6168/66735_5f1dc8fa7488281a_logo.jpg" srcset=""/></p>
<p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://www.newsfilecorp.com/redirect/0Qv0TrmOo" rel="noopener noreferrer" target="_blank">https://www.newsfilecorp.com/release/66735</a></p>
<p><img alt="" class="lazy" data-src="https://www.newsfilecorp.com/newsinfo/66735/310" data-srcset="" src="https://www.newsfilecorp.com/newsinfo/66735/310" srcset=""/></p>
</div>
<p>News Provided by Newsfile via QuoteMedia</p>
<p></p><div class="stock-information sidebar-block">
<div class="title">Request an Investor Kit: <h3>BioHarvest Sciences</h3></div>
<form action="https://investingnews.com" id="subscribe_per_category" method="POST">
<div class="form-column left">
<input name="profiles_only" type="hidden" value="yes"/><input name="subscription_form" type="hidden" value="yes"/><input name="subscribe_company_profile_form" type="hidden" value="1"/><input name="source" type="hidden" value="https://investingnews.com/news/biotech-investing/bioharvest-sciences-inc.appoints-world-renowned-medical-physician-and-nutritionist-to-company-advisory-board/"/><input name="form_name" type="hidden" value="subscribe_cprofile_use_posts"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="cprofiles[]" type="hidden" value="Tzo4OiJzdGRDbGFzcyI6NDp7czoyOiJpZCI7czozNjoiYWJhZmU3MTgtNmUzMC1hYTc0LWVhNjctNWQyNzRhNGY2NjQ1IjtzOjQ6Im5hbWUiO3M6MTk6IkJpb0hhcnZlc3QgU2NpZW5jZXMiO3M6NDoid3BpZCI7czo5OiIxMDE1MTUyMTYiO3M6MzoidXJsIjtzOjA6IiI7fQ=="/><input class="form-control" id="FirstName" name="first_name" placeholder="First Name" required="" type="text" value=""/><input class="form-control" id="LastName" name="last_name" placeholder="Last Name" required="" type="text" value=""/><input class="form-control" id="email" name="email" placeholder="Email" required="" type="email" value=""/><input class="form-control" id="phone" name="user_phone" pattern="[\+\s0-9]{3,15}" placeholder="Phone" title="Telephone number. Only digits and space signs are allowed" type="tel" value=""/></div>
<div class="form-column right">
<div class="extra-input">
<input id="AccreditedInvestor" name="accredited_investor" type="checkbox"/><label class="checkbox-label" for="AccreditedInvestor">
Include me in the <b>Accredited Investor</b> email list
<span class="help">
<i aria-hidden="true" class="fa fa-question-circle"></i>
<div class="help-box bigger">
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above.
</div>
</span>
</label>
</div>
<div class="more">
<input class="btn btn-primary" type="submit" value="Get More information"/></div>
<p class="legend">By completing this form, you are giving consent to receive communication from BioHarvest Sciences using the contact information you provide. And remember you can unsubscribe at any time.</p>
</div>
</form>
</div>
Keep reading...
Show less
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.
To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
<p>According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Aurora had significantly overpaid for previous acquisitions and experienced degradation in certain assets, including its production facilities and inventory; (2) Aurora’s purported “business transformation plan” and cost reset failed to mitigate the foregoing issues; (3) accordingly, it was foreseeable that Aurora would record significant goodwill and asset impairment charges; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.</p>
<p>A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court <b>no later than December 1, 2020</b>. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to <a href="https://www.newsfilecorp.com/redirect/qvgVtQXAg" rel="noopener noreferrer" target="_blank">http://www.rosenlegal.com/cases-register-1965.html</a> or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at <a href="mailto:pkim@rosenlegal.com" rel="noopener noreferrer" target="_blank">pkim@rosenlegal.com</a> or <a href="mailto:cases@rosenlegal.com" rel="noopener noreferrer" target="_blank">cases@rosenlegal.com</a>.</p>
<p>NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.</p>
<p>Follow us for updates on LinkedIn: <a href="https://www.newsfilecorp.com/redirect/n3gXu7b1G" rel="noopener noreferrer" target="_blank">https://www.linkedin.com/company/the-rosen-law-firm</a>, on Twitter: <a href="https://www.newsfilecorp.com/redirect/Ka5DC7vLE" rel="noopener noreferrer" target="_blank">https://twitter.com/rosen_firm</a> or on Facebook: <a href="https://www.newsfilecorp.com/redirect/E73xh0A1X" rel="noopener noreferrer" target="_blank">https://www.facebook.com/rosenlawfirm/</a>. </p>
<p>Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.</p>
<p>——————————-</p>
<p>Contact Information:</p>
<p> Laurence Rosen, Esq.<br/> Phillip Kim, Esq.<br/> The Rosen Law Firm, P.A.<br/> 275 Madison Avenue, 40th Floor<br/> New York, NY 10016<br/> Tel: (212) 686-1060<br/> Toll Free: (866) 767-3653<br/> Fax: (212) 202-3827<br/><a href="mailto:lrosen@rosenlegal.com" rel="noopener noreferrer" target="_blank">lrosen@rosenlegal.com</a><br/><a href="mailto:pkim@rosenlegal.com" rel="noopener noreferrer" target="_blank">pkim@rosenlegal.com</a><br/><a href="mailto:cases@rosenlegal.com" rel="noopener noreferrer" target="_blank">cases@rosenlegal.com</a><br/><a href="https://www.newsfilecorp.com/redirect/x50QUJY7p" rel="noopener noreferrer" target="_blank">www.rosenlegal.com</a></p>
<p id="corporateNewsLogoContainer"><img alt="Corporate Logo" class="lazy" data-src="https://orders.newsfilecorp.com/files/7397/66722_87c94efce4e8f9aa_logo.jpg" data-srcset="" id="corporateNewsLogo" src="https://orders.newsfilecorp.com/files/7397/66722_87c94efce4e8f9aa_logo.jpg" srcset=""/></p>
<p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://www.newsfilecorp.com/redirect/7O5xf7vbb" rel="noopener noreferrer" target="_blank">https://www.newsfilecorp.com/release/66722</a></p>
<p><img alt="" class="lazy" data-src="https://www.newsfilecorp.com/newsinfo/66722/310" data-srcset="" src="https://www.newsfilecorp.com/newsinfo/66722/310" srcset=""/></p>
</div>
<p>News Provided by Newsfile via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing">
<img alt="US Election and Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/10/US-Election-2020-and-Cannabis-3D.jpg" title="US Election 2020 and Cannabis"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing">
<h2 align="center" class="ofie">US Election 2020 and Cannabis</h2></a>
<h5 align="center" class="subheadline">Investing in cannabis? Read what experts have to say about cannabis and the US Election!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/us-election-2020-and-cannabis/" id="Type: Special, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less